TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07228026: Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

Sponsor: Biometry Inc · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 160 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$1,690,500

Rescue Site Savings

+$1,104,000

Unlock Full NCT07228026 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07228026 Rescue Dossier →